New data from startup TrialJectory shows that most cancer patients want to be more involved in their treatment decisions since the pandemic and 93% are open to participating in clinical trials.
New data from startup TrialJectory shows that most cancer patients want to be more involved in their treatment decisions since the pandemic and 93% are open to participating in clinical trials.